Having applications in clinical medicine and preclinical research, TomoWave is structured around production of innovative imaging modalities based on âlistening to the sound of lightâ. The firm's platform technology has relevance to detection and diagnostics of cancer, image guided interventions andto monitoring the effectiveness of anticancer therapy and diagnostics imaging of vascular and blood related conditions. A pipeline of innovative optoacoustic and laser ultrasonic imaging technologies based on the inventions byTomoWave's founder generates intellectual property which is being validated through clinical prototypes bringing thee technologies to the market place through regulatory certification. The marketing of the first product for preclinical research involves a first clinical product for 3D screening, diagnostics and monitoring breast cancer that is being validated at MD Anderson Cancer Cen
